Publications by authors named "Sofie Mylle"

In dermatology, deep learning may be applied for skin lesion classification. However, for a given input image, a neural network only outputs a label, obtained using the class probabilities, which do not model uncertainty. Our group developed a novel method to quantify uncertainty in stochastic neural networks.

View Article and Find Full Text PDF

We present a case of Nocardia farcinica after placement of reverse shoulder prosthesis in a 73-year-old woman. One month after surgery, the patient was admitted to the hospital with a spontaneous drainage of the wound and complaints of aggravating pain in the operated shoulder. There was no history of an immunosuppressive disease or therapy.

View Article and Find Full Text PDF
Article Synopsis
  • Dermoscopy is widely used in dermatology for skin cancer diagnosis, but traditional methods rely on analogue white light, while multispectral dermoscopy uses different wavelengths of light to enhance visualization of skin features.
  • This technique produces "skin parameter maps" that highlight the concentration of pigment and blood in skin lesions, which is particularly useful for identifying keratinocyte skin cancers like basal cell carcinoma and Bowen's disease.
  • The study concludes that these maps offer a more detailed understanding of skin lesions' inner structures and can serve as a valuable complement to conventional dermoscopy for improved diagnosis.
View Article and Find Full Text PDF

Multiple reports confirm elevated circulating IL-17 levels and increased numbers of Th17 lymphocytes in patients with non-segmental vitiligo. Additionally, melanocyte damaging characteristics have been ascribed to IL-17. A single-arm pilot study using secukinumab in active non-segmental vitiligo was conducted.

View Article and Find Full Text PDF

New promising treatments have been developed for psoriasis that target different parts of the interleukin (IL)-23/IL-17 pathway. This approach is believed to be more disease specific, and sparing the T helper 1 pathway might prevent serious long-term adverse events. Moreover, superior Psoriasis Area and Severity Index improvements are observed, which has redefined treatment goals in psoriasis.

View Article and Find Full Text PDF